University of Natural Resources and Life Sciences, Vienna (BOKU) - Research portal

Logo BOKU Resarch Portal

Publications

Search Items: Antibodies, Monoclonal - immunology , . hits: 55


** = Publications listed in SCI/SSCI - Journals (published in Web of Science)
* = peer-reviewed publication (not listed in SCI/SSCI)
Only: Full paper/article, Review, Proceedings Paper

2010

** Apellaniz, B; García-Sáez, AJ; Huarte, N; Kunert, R; Vorauer-Uhl, K; Katinger, H; Schwille, P; Nieva, JL Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids..

FEBS Lett. 2010; 584(8):1591-1596 WoS PubMed FullText FullText_BOKU

2009

** Arnold, GF; Velasco, PK; Holmes, AK; Wrin, T; Geisler, SC; Phung, P; Tian, Y; Resnick, DA; Ma, X; Mariano, TM; Petropoulos, CJ; Taylor, JW; Katinger, H; Arnold, E Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope..

J Virol. 2009; 83(10):5087-5100 WoS PubMed PUBMED Central FullText FullText_BOKU

** Gruber, P; Gadermaier, G; Bauer, R; Weiss, R; Wagner, S; Leonard, R; Breiteneder, H; Ebner, C; Ferreira, F; Egger, M Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen allergen..

Biol Chem. 2009; 390(5-6):445-451 WoS PubMed FullText FullText_BOKU

2008

** Dürauer, A; Berger, E; Zandian, M; Mersich, C; Schuster, M; Loibner, H; Jungbauer, A Yeast cell surface display system for determination of humoral response to active immunization with a monoclonal antibody against EpCAM..

J Biochem Biophys Methods. 2008; 70(6):1109-1115 WoS PubMed FullText FullText_BOKU

** Gach, JS; Quendler, H; Strobach, S; Katinger, H; Kunert, R Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5..

Mol Immunol. 2008; 45(4):1027-1034 WoS PubMed FullText FullText_BOKU

** Huarte, N; Lorizate, M; Kunert, R; Nieva, JL Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies..

FEBS Lett. 2008; 582(27):3798-3804 WoS PubMed FullText FullText_BOKU

** Huarte, N; Lorizate, M; Maeso, R; Kunert, R; Arranz, R; Valpuesta, JM; Nieva, JL The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5..

J Virol. 2008; 82(18):8986-8996 WoS PubMed PUBMED Central FullText FullText_BOKU

** Trkola, A; Kuster, H; Rusert, P; von Wyl, V; Leemann, C; Weber, R; Stiegler, G; Katinger, H; Joos, B; Günthard, HF In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers..

J Virol. 2008; 82(3):1591-1599 WoS PubMed PUBMED Central FullText FullText_BOKU

2007

** Ferrantelli, F; Buckley, KA; Rasmussen, RA; Chalmers, A; Wang, T; Li, PL; Williams, AL; Hofmann-Lehmann, R; Montefiori, DC; Cavacini, LA; Katinger, H; Stiegler, G; Anderson, DC; McClure, HM; Ruprecht, RM Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques..

Virology. 2007; 358(1):69-78 WoS PubMed FullText FullText_BOKU

** Gach, JS; Quendler, H; Weik, R; Katinger, H; Kunert, R Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?.

AIDS Res Hum Retroviruses. 2007; 23(11):1405-1415 WoS PubMed FullText FullText_BOKU

** Manrique, A; Rusert, P; Joos, B; Fischer, M; Kuster, H; Leemann, C; Niederöst, B; Weber, R; Stiegler, G; Katinger, H; Günthard, HF; Trkola, A In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10..

J Virol. 2007; 81(16):8793-8808 WoS PubMed PUBMED Central FullText FullText_BOKU

** Schabussova, I; Amer, H; van Die, I; Kosma, P; Maizels, RM O-methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections..

Int J Parasitol. 2007; 37(1):97-109 WoS PubMed FullText FullText_BOKU

2006

** Dürauer, A; Berger, E; Schuster, M; Wasserbauer, E; Himmler, G; Loibner, H; Mudde, GC; Jungbauer, A Peptide arrays for the determination of humoral responses induced by active immunization with a monoclonal antibody against EpCAM..

J Immunol Methods. 2006; 317(1-2):114-125 WoS PubMed FullText FullText_BOKU

** Sánchez-Martínez, S; Lorizate, M; Katinger, H; Kunert, R; Nieva, JL Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies..

AIDS Res Hum Retroviruses. 2006; 22(10):998-1006 WoS PubMed FullText FullText_BOKU

* Zhang, MY; Choudhry, V; Sidorov, IA; Tenev, V; Vu, BK; Choudhary, A; Lu, H; Stiegler, GM; Katinger, HW; Jiang, S; Broder, CC; Dimitrov, DS (2006): Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning..

J Immunol Methods. 2006; 317(1-2):21-30 PubMed PUBMED Central FullText FullText_BOKU

2005

** Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies..

Science. 2005; 308(5730):1906-1908 WoS PubMed FullText FullText_BOKU

** Nakowitsch, S; Quendler, H; Fekete, H; Kunert, R; Katinger, H; Stiegler, G HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies..

AIDS. 2005; 19(17):1957-1966 WoS PubMed FullText FullText_BOKU

2004

** Bencúrová, M; Hemmer, W; Focke-Tejkl, M; Wilson, IB; Altmann, F Specificity of IgG and IgE antibodies against plant and insect glycoprotein glycans determined with artificial glycoforms of human transferrin..

Glycobiology. 2004; 14(5):457-466 WoS PubMed FullText FullText_BOKU

** Binley, JM; Wrin, T; Korber, B; Zwick, MB; Wang, M; Chappey, C; Stiegler, G; Kunert, R; Zolla-Pazner, S; Katinger, H; Petropoulos, CJ; Burton, DR Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies..

J Virol. 2004; 78(23):13232-13252 WoS PubMed PUBMED Central FullText FullText_BOKU

** de Rosny, E; Vassell, R; Jiang, S; Kunert, R; Weiss, CD Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes..

J Virol. 2004; 78(5):2627-2631 WoS PubMed PUBMED Central FullText FullText_BOKU

** Ferrantelli, F; Kitabwalla, M; Rasmussen, RA; Cao, C; Chou, TC; Katinger, H; Stiegler, G; Cavacini, LA; Bai, Y; Cotropia, J; Ugen, KE; Ruprecht, RM Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine..

J Infect Dis. 2004; 189(1):71-74 WoS PubMed FullText FullText_BOKU

** Roux, KH; Zhu, P; Seavy, M; Katinger, H; Kunert, R; Seamon, V Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12..

Mol Immunol. 2004; 41(10):1001-1011 WoS PubMed FullText FullText_BOKU

2003

** Kitabwalla, M; Ferrantelli, F; Wang, T; Chalmers, A; Katinger, H; Stiegler, G; Cavacini, LA; Chou, TC; Ruprecht, RM Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B..

AIDS Res Hum Retroviruses. 2003; 19(2):125-131 WoS PubMed FullText FullText_BOKU

2002

** Brade, L; Gronow, S; Wimmer, N; Kosma, P; Brade, H Monoclonal antibodies against 3-deoxy-alpha-D-manno-oct-2-ulosonic acid (Kdo) and D-glycero-alpha-D-talo-oct-2-ulosonic acid (Ko)..

J Endotoxin Res. 2002; 8(5):357-364 WoS PubMed FullText FullText_BOKU

** Hofmann-Lehmann, R; Vlasak, J; Rasmussen, RA; Jiang, S; Li, PL; Baba, TW; Montefiori, DC; Bernacky, BJ; Rizvi, TA; Schmidt, R; Hill, LR; Keeling, ME; Katinger, H; Stiegler, G; Cavacini, LA; Posner, MR; Ruprecht, RM Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge..

J Med Primatol. 2002; 31(3):109-119 WoS PubMed

** Kunert, RE; Weik, R; Ferko, B; Stiegler, G; Katinger, H Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5..

AIDS. 2002; 16(4):667-668 WoS PubMed

** Sanders, RW; Venturi, M; Schiffner, L; Kalyanaraman, R; Katinger, H; Lloyd, KO; Kwong, PD; Moore, JP The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120..

J Virol. 2002; 76(14):7293-7305 WoS PubMed PUBMED Central FullText FullText_BOKU

** Scanlan, CN; Pantophlet, R; Wormald, MR; Ollmann Saphire, E; Stanfield, R; Wilson, IA; Katinger, H; Dwek, RA; Rudd, PM; Burton, DR The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120..

J Virol. 2002; 76(14):7306-7321 WoS PubMed PUBMED Central FullText FullText_BOKU

2001

** Einhauer, A; Jungbauer, A Affinity of the monoclonal antibody M1 directed against the FLAG peptide..

J Chromatogr A. 2001; 921(1):25-30 WoS PubMed

** Parker, CE; Deterding, LJ; Hager-Braun, C; Binley, JM; Schülke, N; Katinger, H; Moore, JP; Tomer, KB Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5..

J Virol. 2001; 75(22):10906-10911 WoS PubMed PUBMED Central FullText FullText_BOKU

** Xu, W; Smith-Franklin, BA; Li, PL; Wood, C; He, J; Du, Q; Bhat, GJ; Kankasa, C; Katinger, H; Cavacini, LA; Posner, MR; Burton, DR; Chou, TC; Ruprecht, RM Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B..

J Hum Virol. 2001; 4(2):55-61 WoS PubMed

** Zwick, MB; Labrijn, AF; Wang, M; Spenlehauer, C; Saphire, EO; Binley, JM; Moore, JP; Stiegler, G; Katinger, H; Burton, DR; Parren, PW Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41..

J Virol. 2001; 75(22):10892-10905 WoS PubMed PUBMED Central FullText FullText_BOKU

** Zwick, MB; Wang, M; Poignard, P; Stiegler, G; Katinger, H; Burton, DR; Parren, PW Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies..

J Virol. 2001; 75(24):12198-12208 WoS PubMed PUBMED Central FullText FullText_BOKU

2000

** Baba, TW; Liska, V; Hofmann-Lehmann, R; Vlasak, J; Xu, W; Ayehunie, S; Cavacini, LA; Posner, MR; Katinger, H; Stiegler, G; Bernacky, BJ; Rizvi, TA; Schmidt, R; Hill, LR; Keeling, ME; Lu, Y; Wright, JE; Chou, TC; Ruprecht, RM Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection..

Nat Med. 2000; 6(2):200-206 WoS PubMed FullText FullText_BOKU

** Uhde, K; Kerschbaumer, RJ; Koenig, R; Hirschl, S; Lemaire, O; Boonham, N; Roake, W; Himmler, G Improved detection of Beet necrotic yellow vein virus in a DAS ELISA by means of antibody single chain fragments (scFv) which were selected to protease-stable epitopes from phage display libraries.

ARCH VIROL. 2000; 145(1): 179-185. WoS PubMed

1998

** Breitwieser, A; Mader, C; Schocher, I; Hoffmann-Sommergruber, K; Aberer, W; Scheiner, O; Sleytr, UB; Sára, M A novel dipstick developed for rapid Bet v 1-specific IgE detection: recombinant allergen immobilized via a monoclonal antibody to crystalline bacterial cell-surface layers..

Allergy. 1998; 53(8):786-793 WoS PubMed FullText FullText_BOKU

** Li, A; Katinger, H; Posner, MR; Cavacini, L; Zolla-Pazner, S; Gorny, MK; Sodroski, J; Chou, TC; Baba, TW; Ruprecht, RM Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins..

J Virol. 1998; 72(4):3235-3240 WoS PubMed PUBMED Central

1997

** Brade, L; Zych, K; Rozalski, A; Kosma, P; Bock, K; Brade, H Structural requirements of synthetic oligosaccharides to bind monoclonal antibodies against Chlamydia lipopolysaccharide..

Glycobiology. 1997; 7(6):819-827 WoS PubMed

** Li, A; Baba, TW; Sodroski, J; Zolla-Pazner, S; Gorny, MK; Robinson, J; Posner, MR; Katinger, H; Barbas, CF; Burton, DR; Chou, TC; Ruprecht, RM Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins..

AIDS Res Hum Retroviruses. 1997; 13(8):647-656 WoS PubMed

** Rozalski, A; Brade, L; Kosma, P; Moxon, R; Kusumoto, S; Brade, H Characterization of monoclonal antibodies recognizing three distinct, phosphorylated carbohydrate epitopes in the lipopolysaccharide of the deep rough mutant I-69 Rd-/b+ of Haemophilus influenzae..

Mol Microbiol. 1997; 23(3):569-577 WoS PubMed

** Stoiber, H; Frank, I; Spruth, M; Schwendinger, M; Mullauer, B; Windisch, JM; Schneider, R; Katinger, H; Ando, I; Dierich, MP Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?.

Mol Immunol. 1997; 34(12-13):855-863 WoS PubMed

1996

** Purtscher, M; Trkola, A; Grassauer, A; Schulz, PM; Klima, A; Döpper, S; Gruber, G; Buchacher, A; Muster, T; Katinger, H Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5..

AIDS. 1996; 10(6):587-593 WoS PubMed

** Trkola, A; Purtscher, M; Muster, T; Ballaun, C; Buchacher, A; Sullivan, N; Srinivasan, K; Sodroski, J; Moore, JP; Katinger, H Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1..

J Virol. 1996; 70(2):1100-1108 WoS PubMed PUBMED Central FullText

1995

** Stigler, RD; Rüker, F; Katinger, D; Elliott, G; Höhne, W; Henklein, P; Ho, JX; Keeling, K; Carter, DC; Nugel, E Interaction between a Fab fragment against gp41 of human immunodeficiency virus 1 and its peptide epitope: characterization using a peptide epitope library and molecular modeling..

Protein Eng. 1995; 8(5):471-479 WoS PubMed FullText FullText_BOKU

** Trkola, A; Pomales, AB; Yuan, H; Korber, B; Maddon, PJ; Allaway, GP; Katinger, H; Barbas, CF; Burton, DR; Ho, DD Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG..

J Virol. 1995; 69(11):6609-6617 WoS PubMed PUBMED Central FullText

1994

** Brade, L; Brunnemann, H; Ernst, M; Fu, Y; Holst, O; Kosma, P; Näher, H; Persson, K; Brade, H Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen..

FEMS Immunol Med Microbiol. 1994; 8(1):27-41 WoS PubMed

* Chen, YH; Böck, G; Vornhagen, R; Steindl, F; Katinger, H; Dierich, MP (1994): HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41..

Mol Immunol. 1994; 31(13):977-982 PubMed

** Lim, K; Ho, JX; Keeling, K; Gilliland, GL; Ji, X; Rüker, F; Carter, DC Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV..

Protein Sci. 1994; 3(12):2233-2244 WoS PubMed PUBMED Central FullText FullText_BOKU

* van der Meer, NM; Appelmelk, BJ; Verweij-van Vught, AM; Nimmich, W; Kosma, P; Thijs, LG; de Graaff, J; MacLaren, DM (1994): Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes..

Infect Immun. 1994; 62(3):1052-1057 PubMed PUBMED Central

1993

** Muster, T; Steindl, F; Purtscher, M; Trkola, A; Klima, A; Himmler, G; Rüker, F; Katinger, H A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1..

J Virol. 1993; 67(11):6642-6647 WoS PubMed PUBMED Central

1992

** Pedron, T; Girard, R; Kosma, P; Chaby, R Preparation and binding specificity of a monoclonal antibody recognizing 3-deoxy-D-manno-2-octulosonic acid (Kdo) in lipopolysaccharides of Re chemotype..

Hybridoma. 1992; 11(6):765-777 WoS PubMed

1991

* Holst, O; Brade, L; Kosma, P; Brade, H (1991): Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp..

J Bacteriol. 1991; 173(6):1862-1866 PubMed PUBMED Central

1990

** Wenisch, E; Reiter, S; Hinger, S; Steindl, F; Tauer, C; Jungbauer, A; Katinger, H; Righetti, PG Shifts of isoelectric points between cellular and secreted antibodies as revealed by isoelectric focusing and immobilized pH gradients..

Electrophoresis. 1990; 11(11):966-969 WoS PubMed FullText FullText_BOKU

1988

** Grunow, R; Jahn, S; Porstmann, T; Kiessig, SS; Steinkellner, H; Steindl, F; Mattanovich, D; Gürtler, L; Deinhardt, F; Katinger, H The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus..

J Immunol Methods. 1988; 106(2):257-265 WoS PubMed

1985

** Merten, OW; Heberle-Bors, E; Himmler, G; Reiter, S; Messner, P; Katinger, H Monoclonal ELISA for the determination of BNYV-virus..

Dev Biol Stand. 1985; 60:451-456 WoS PubMed

↑ Top of page / Navigation

↑ Top of page / Navigation

© BOKU Wien • Imprint